Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: The American college of surgeons oncology group z0011 randomized trial Academic Article uri icon

Overview

MeSH Major

  • Breast Neoplasms
  • Lymph Node Excision
  • Lymphatic Metastasis
  • Sentinel Lymph Node Biopsy

abstract

  • Despite the potential for residual axillary disease after SLND, SLND without ALND can offer excellent regional control and may be reasonable management for selected patients with early-stage breast cancer treated with breast-conserving therapy and adjuvant systemic therapy.

publication date

  • January 2010

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC5593421

Digital Object Identifier (DOI)

  • 10.1097/SLA.0b013e3181f08f32

PubMed ID

  • 20739842

Additional Document Info

start page

  • 426

end page

  • 32; discussion 432-3

volume

  • 252

number

  • 3